Listing Date Delayed for Paid-in Capital Increase
한국유니온제약
080720
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=2740
Risk-adjusted indicator based on 2740 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Original Listing Date: August 18, 2026
- • Amended Listing Date: August 28, 2026
- • Effectiveness Date of Capital Increase: May 28, 2026
AI Analysis Summary
UNION KOREA PHARM CO.,Ltd announced an amendment to its Material Fact Report regarding a paid-in capital increase. The primary change is a delay in the new shares' listing date from August 18, 2026, to August 28, 2026, due to administrative procedures with the Korea Securities Depository. This capital increase is part of a rehabilitation plan approved by the Seoul Rehabilitation Court on May 12, 2026, which also includes a debt-to-equity swap (effective May 19, 2026) and a capital reduction (effective May 27, 2026). The third-party allocation capital increase is expected to result in a change of the largest shareholder. The delay in listing is a minor procedural adjustment and does not alter the fundamental financial impact of the capital increase, which is part of a broader corporate rehabilitation effort.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.